Preliminary Results of Phase I/II Study of Clofarabine (CLO) in Combination With Cytarabine and Total Body Irradiation (TBI) Followed by Allogeneic Stem Cell Transplantation (AlloSCT) in Children, Adolescents and Young Adults (CAYA) With Poor-Risk Acute Leukemia